This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignee: Array Biopharma Inc.. Active years: 2013-2020.
Location History:
- Boulder, CO (US) (2013 - 2015)
- Lyons, CO (US) (2014 - 2020)
Company Filing History:
Years Active: 2013-2020
Title: The Innovative Contributions of Robert Kirk DeLisle
Introduction
Robert Kirk DeLisle is a prominent inventor based in Lyons, Colorado, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, DeLisle has made remarkable advancements in the development of compounds that target various medical conditions.
Latest Patents
His latest patents include the development of substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds, which serve as type III receptor tyrosine kinase inhibitors. These compounds are designed to be effective in treating fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain, and burns in mammals. The innovative nature of these compounds highlights DeLisle's commitment to addressing critical health issues through scientific research.
Career Highlights
DeLisle is currently employed at Array Biopharma Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the advancement of medical treatments but has also positioned him as a key figure in the industry.
Collaborations
Throughout his career, DeLisle has collaborated with notable colleagues, including Qian Zhao and Mark C Munson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Robert Kirk DeLisle's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for new treatments that can significantly improve patient outcomes.